↓ Skip to main content

Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators

Overview of attention for article published in Cochrane database of systematic reviews, January 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

blogs
2 blogs

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Published in
Cochrane database of systematic reviews, January 2005
DOI 10.1002/14651858.cd001276.pub2
Pubmed ID
Authors

A Mitra, D Bassler, K Goodman, T J Lasserson, F M Ducharme, Mitra A, Bassler D, Goodman K, Lasserson TJ, Ducharme FM, Mitra AAD; Bassler D; Watts K; Lasserson TJ; Ducharme FM

Abstract

Since the advent of inhaled beta2-agonists, anticholinergic agents and glucocorticoids, the role of aminophylline in paediatric acute asthma has become less clear. There remains some consensus that it is beneficial in children with acute severe asthma, receiving maximised therapy (oxygen, inhaled bronchodilators, and glucocorticoids).

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 2 6%
Japan 1 3%
United States 1 3%
Saudi Arabia 1 3%
Unknown 27 84%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 19%
Professor > Associate Professor 6 19%
Other 5 16%
Student > Master 4 13%
Student > Bachelor 3 9%
Other 10 31%
Readers by discipline Count As %
Medicine and Dentistry 25 78%
Unspecified 2 6%
Nursing and Health Professions 2 6%
Arts and Humanities 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 9%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2013.
All research outputs
#285,751
of 3,626,596 outputs
Outputs from Cochrane database of systematic reviews
#1,455
of 6,234 outputs
Outputs of similar age
#10,643
of 93,329 outputs
Outputs of similar age from Cochrane database of systematic reviews
#20
of 65 outputs
Altmetric has tracked 3,626,596 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,234 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 10.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 93,329 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.